interferoninduc
transmembran
protein
ifitm
emerg
import
gatekeep
pathogen
infect
initi
sirna
knockdown
studi
increas
suscept
mammalian
cell
line
influenza
viru
iav
overexpress
show
could
also
inhibit
infect
strain
iav
well
flavivirus
west
nile
viru
wnv
dengu
viru
denv
activ
addit
human
two
ifitm
isoform
mice
four
other
induc
subsequ
studi
demonstr
activ
mani
includ
ebola
viru
ebov
vesicular
stomat
viru
vsv
sar
coronaviru
sarscov
human
immunodefici
viru
hiv
respiratori
syncyti
viru
rsv
nonenvelop
mammalian
reoviru
hepat
c
viru
hcv
zika
viru
zikv
ifitm
howev
activ
dna
virus
papillomaviru
cytomegaloviru
even
promot
human
coronaviru
sirna
knockdown
togeth
also
report
increas
mycobacterium
tuberculosi
mtb
infect
moreov
shown
associ
mtb
late
endosom
compart
shown
restrict
mtb
imag
flow
ifitm
activ
multipl
mammalian
cell
type
includ
primari
cell
respiratori
dc
directli
involv
adapt
immun
notabl
mice
suscept
infect
moreov
appear
import
intrins
induc
antivir
activ
human
embryon
stem
ifitm
also
suggest
limit
viru
infect
varieti
highlight
possibl
evolutionarilyconserv
function
host
immun
ifitm
encod
rel
small
membran
protein
amino
acid
origin
predict
dualpass
transmembran
protein
base
two
hydrophob
fig
howev
subsequ
epitop
map
studi
preliminari
structur
studi
suggest
ifitm
type
iv
membran
protein
second
hydrophob
domain
transmembran
domain
cterminu
face
outsid
cell
contrast
first
hydrophob
domain
suggest
function
amphipath
helix
regul
interact
inner
leaflet
host
ifitm
membran
topolog
model
also
support
discoveri
posttransl
modif
sfattyacyl
phosphoryl
ubiquitin
well
methyl
mammalian
cell
mostli
distribut
earli
late
endocyt
vesicl
lysosom
live
cell
imag
truncat
nterminu
lack
sort
motif
found
show
plasma
membran
cellular
local
ifitm
may
crucial
determin
specif
toward
virus
sinc
activ
virus
enter
plasma
membran
earli
endocyt
vesicl
wherea
activ
virus
enter
within
late
endocyt
human
individu
snp
allel
encod
predict
acid
truncat
nterminu
show
increas
morbid
mortal
strain
allel
preval
asian
associ
fatal
iav
well
acut
howev
recent
overexpress
direct
transcript
challeng
signific
allel
human
studi
snp
identifi
anoth
lossoffunct
allel
utr
result
lower
mrna
express
correl
reduc
number
cell
patient
airway
increas
sever
influenzamedi
studi
highlight
ifitm
highli
regul
mammalian
cell
import
host
suscept
divers
pathogen
express
level
subcellular
local
mutat
clearli
modul
host
suscept
toward
differ
virus
precis
cellular
biochem
mechan
ifitm
inhibit
viru
entri
ifnstimul
cell
still
overexpress
studi
show
ifitm
affect
express
level
host
ligandsreceptor
virus
eg
sialic
acid
level
uptak
iav
particl
mammalian
suggest
small
membran
protein
may
interfer
intermedi
late
stage
viru
entri
rather
initi
bind
intern
host
cell
notabl
overexpress
appear
arrest
intern
viru
particl
within
endocyt
vesicl
prevent
transloc
viral
content
overexpress
studi
also
suggest
expand
late
endocyt
potenti
alter
local
activ
without
affect
lysosom
cathepsin
altern
overexpress
studi
also
suggest
ifitm
influenc
cellcel
indirectli
alter
intracellular
cholesterol
block
viral
hemifus
host
membran
howev
live
cell
imag
iav
entri
lipid
mix
shown
ifitm
affect
viru
hemifus
local
indic
possibl
role
block
fusion
pore
format
interestingli
ifitm
may
also
incorpor
virion
virus
inhibit
viru
spread
transfer
exosom
propag
antivir
activ
neighbor
broad
activ
ifitm
differ
class
virus
perhap
even
intracellular
bacteri
pathogen
suggest
gener
mechan
action
function
mani
differ
cell
type
howev
lack
mutant
cell
line
tool
live
imag
ifitm
limit
direct
mechanist
investig
host
cell
infect
well
dissect
regulatori
mechan
address
antivir
mechan
ifitm
interact
virus
mammalian
cell
gener
human
mutant
cell
line
gene
edit
establish
sitespecif
fluorophor
label
live
cell
imag
viru
infect
discov
act
cooper
ifnstimul
cell
divers
virus
iav
vsv
denv
wnv
zikv
enhanc
traffick
endogen
activ
egfr
exogen
viru
particl
cargo
late
endocyt
vesicl
lysosom
degrad
use
live
cell
imag
experi
observ
intern
iav
particl
primarili
undergo
lipid
mix
hemifus
host
membran
fusion
virusbear
vesicl
vesicl
prefus
coloc
viru
particl
vesicl
specif
restrict
virus
iav
ebov
markedli
decreas
lossoffunct
mutant
snp
allel
also
demonstr
sitespecif
sfattyacyl
import
traffick
incom
iav
particl
collect
result
show
engag
vesicl
bear
incom
viru
particl
promot
shuttl
late
endocyt
cargo
lysosom
degrad
highlight
gener
mechan
ifitm
may
intercept
pathogen
prevent
entri
host
cell
studi
uniqu
enabl
sitespecif
protein
label
imag
method
also
facilit
function
analysi
host
factor
involv
pathogen
restrict
well
mechan
regul
evalu
antivir
activ
endogen
express
human
ifitm
employ
gene
edit
gener
human
knockout
ko
cell
line
hela
cervic
epitheli
cell
lung
epitheli
cell
normal
express
high
level
human
follow
ifnstimul
supplementari
result
fig
amongst
grna
evalu
target
exon
human
supplementari
result
supplementari
fig
afford
effici
cleavag
genom
supplementari
result
supplementari
fig
western
blot
analysi
transfect
stabl
cell
clone
puromycin
select
yield
sever
hela
clone
decreas
andor
delet
use
nterminallydirect
antibodi
crossreact
protein
supplementari
result
supplementari
fig
sinc
human
high
sequenc
ident
first
exon
also
flank
chromosom
evalu
express
use
isoformspecif
antibodi
fig
analysi
identifi
hela
cell
clone
reduc
express
well
one
clone
show
loss
express
compar
vectortr
hela
cell
wt
hela
fig
cell
isol
doubl
ko
clone
partial
reduc
express
fig
summari
mutat
hela
mutant
cell
line
includ
supplementari
result
tabl
next
evalu
viru
suscept
hela
ifitm
mutant
cell
line
without
treatment
infect
hela
cell
clone
iav
strain
show
reduc
express
increas
viru
suscept
approxim
respect
compar
control
fig
supplementari
result
supplementari
fig
howev
hela
cell
clone
complet
loss
three
isoform
exhibit
greater
increas
infect
judg
antiinfluenza
viru
nucleoprotein
np
stain
fig
supplementari
result
supplementari
fig
cooper
antivir
activ
among
ifitm
even
pronounc
treat
cell
reduc
express
alon
signific
effect
iav
infect
wherea
delet
three
isoform
result
greater
increas
suscept
fig
supplementari
result
supplementari
fig
signific
differ
iav
infect
clone
ko
three
isoform
observ
even
treatment
fig
supplementari
result
supplementari
fig
suggest
play
signific
role
prevent
iav
infect
contrast
analysi
ifitm
mutant
cell
line
virus
show
vsv
venezuelan
equin
enceph
viru
veev
infect
hela
cell
clone
similar
level
treatment
reduc
express
delet
increas
infect
particularli
three
isoform
delet
supplementari
result
supplementari
fig
denv
also
show
increas
infect
ifitmmut
hela
cell
line
supplementari
result
supplementari
fig
howev
loss
express
alon
treat
cell
partial
attenu
denv
infect
compar
hela
cell
without
supplementari
result
supplementari
fig
yfv
nyong
nyong
viru
onnv
show
enhanc
infect
ifitmmut
cell
attenu
treatment
supplementari
result
supplementari
fig
suggest
ifneffector
also
contribut
host
restrict
virus
observ
similar
trend
viru
infect
treat
cell
compar
wildtyp
wt
control
supplementari
result
supplementari
fig
confirm
viru
suscept
inde
due
reduc
express
delet
gener
stabl
clone
reconstitut
hela
clone
gener
cell
express
low
medium
nearwt
level
clone
express
fig
iav
infect
hela
cell
line
show
dosedepend
antivir
activ
express
alon
suffici
render
hela
cell
resist
viru
infect
fig
result
show
human
function
dosedepend
manner
may
redund
toward
virus
may
act
synergist
restrict
broad
spectrum
virus
ifnstimul
cell
endogen
level
ifnstimul
cell
import
iav
veev
wherea
three
ifitm
involv
prevent
vsv
denv
infect
elucid
cellular
mechan
ifitm
inhibit
viru
infect
evalu
local
endogen
endocyt
vesicl
distribut
cargo
traffick
treat
cell
immunofluoresc
analysi
show
endogen
well
reconstitut
present
intracellular
vesicular
structur
partial
coloc
late
endocyt
compart
treat
cell
fig
fluoresc
imag
endocyt
marker
show
signific
differ
distribut
earli
endosom
late
endosom
lysosom
wt
cell
supplementari
result
supplementari
fig
b
also
observ
signific
enlarg
expans
compart
treat
control
cell
compar
cell
supplementari
result
supplementari
fig
b
contrast
previou
overexpress
moreov
uptak
exogen
cargo
dextran
particl
similar
treat
wt
cell
supplementari
result
supplementari
fig
treat
wt
cell
also
exhibit
similar
label
fluorogen
cellpenetr
peptid
enter
endocyt
supplementari
result
supplementari
fig
result
collect
suggest
significantli
regul
earli
endocyt
event
gener
alter
endocyt
vesicl
membran
permeabl
sinc
earli
endocyt
event
affect
endogen
mainli
local
late
endosom
lysosom
evalu
whether
may
affect
late
endocyt
vesicl
cargo
traffick
degrad
initi
pulsechas
label
studi
fluoresc
dextran
particl
suggest
exogen
cargo
traffick
lysosom
modestli
delay
treat
cell
supplementari
result
supplementari
fig
evalu
traffick
degrad
endogen
endocyt
cargo
focus
turnov
activ
epiderm
growth
factor
receptor
egfr
one
major
sialyl
cell
surfac
receptor
readili
detect
cell
cell
surfac
level
egfr
similar
supplementari
result
supplementari
fig
follow
egfstimul
treat
cell
egfr
larg
degrad
minut
fig
c
notabl
egfr
turnov
markedli
delay
treat
cell
signific
level
still
present
minut
fig
c
stabl
reconstitut
treat
cell
rescu
even
acceler
degrad
egfr
fig
c
contrast
treatment
cell
transferrin
tf
time
frame
supplementari
result
supplementari
fig
c
suggest
significantli
affect
turnov
activ
transferrin
receptor
tfr
gpianchor
modifi
membran
protein
recycl
plasma
membran
analysi
lysosom
proteas
activ
use
fluorogen
cathepsin
b
substrat
cystein
proteas
activitybas
profil
show
similar
level
endolysosom
proteolyt
activ
treat
hela
cell
regardless
express
level
supplementari
result
supplementari
fig
e
data
togeth
pulsechas
analysi
fluorescentdextran
particl
suggest
significantli
alter
endolysosom
proteas
activ
may
enhanc
traffick
late
endocyt
cargo
lysosom
degrad
even
absenc
viru
infect
investig
effect
ifitm
viral
entri
traffick
employ
livecel
fluoresc
microscopi
monitor
individu
iav
particl
synchron
infect
use
membraneincorpor
dye
tetramethylindodicarbocyanin
readili
label
iav
particl
vitro
supplementari
result
supplementari
fig
exhibit
fluoresc
dequench
upon
hemifus
full
fusion
viral
endosom
abl
track
viral
membran
fusion
indic
glycoproteinmedi
lipid
mix
monitor
traffick
virusfus
vesicl
iav
known
fuse
late
endosom
first
evalu
iav
lipid
mix
traffick
wt
cell
transduc
express
experi
perform
hela
cell
exhibit
less
contour
cell
enabl
comprehens
quantit
imag
didiav
particl
widefield
epifluoresc
microscopi
iav
lipid
mix
occur
almost
exclus
compart
fig
b
supplementari
result
supplementari
movi
rate
iav
particl
underw
lipid
mix
similar
wt
cell
fig
black
white
circl
approxim
min
treat
cell
didiav
dequench
rate
delay
hela
cell
compar
wt
cell
fig
black
white
squar
lipid
mix
ifntreat
hela
cell
occur
min
later
wt
cell
moreov
traffick
didiav
particl
compart
treat
wt
hela
cell
also
averag
min
faster
even
though
viru
traffick
time
may
vari
wide
even
synchronizedinfect
fig
signific
differ
traffick
didiav
particl
compart
observ
unstimul
cell
fig
treatment
reduc
rel
amount
dequench
didiav
particl
percentag
dequench
didiav
particl
fig
degre
coloc
compart
similar
hela
wt
cell
h
postinfect
fig
result
show
treatment
impact
kinet
total
extent
viral
lipid
mix
cell
versu
wt
cell
suggest
primarili
influenc
rate
viru
traffick
late
endosom
compart
rather
gross
composit
endosom
milieu
consist
data
dextran
particl
traffick
supplementari
result
supplementari
fig
egfr
fig
c
tfr
turnov
supplementari
result
supplementari
fig
c
traffick
ifitm
live
cell
viru
infect
previous
describ
immunofluoresc
electron
microscopi
studi
suggest
local
around
iav
well
mtbcontain
inde
immunofluoresc
studi
also
show
endogen
treat
cell
partial
coloc
intern
iav
particl
visual
antiiav
np
antibodi
stain
supplementari
result
supplementari
fig
perhap
even
surround
viru
particl
imag
higher
resolut
structur
illumin
microscopi
supplementari
result
supplementari
fig
howev
studi
reveal
whether
ifitm
interact
incom
viru
particl
affect
traffick
within
endocyt
compart
address
key
aspect
ifitm
function
viru
entri
recent
optim
sitespecif
fluorophor
label
protein
use
amber
codon
suppressionmedi
unnatur
amino
acid
mutagenesi
evalu
traffick
live
mammalian
briefli
transfect
mammalian
cell
plasmid
encod
mmpylrsafpyltrnacua
plasmid
enabl
sitespecif
incorpor
tcok
subsequ
bioorthogon
label
bodipytetrazin
bodipytz
supplementari
result
supplementari
fig
importantli
label
bodipytz
retain
antivir
activ
toward
iav
supplementari
result
supplementari
fig
analysi
express
level
antibodi
stain
show
sitespecif
label
tcok
cell
yield
slightli
lower
level
total
protein
compar
wt
hela
cell
western
blot
flow
cytometri
analysi
supplementari
result
supplementari
fig
c
similar
pattern
vesicl
stain
immunofluoresc
supplementari
result
supplementari
fig
result
demonstr
tcoklabel
express
level
transient
transfect
within
physiolog
rang
endogen
protein
level
exhibit
compar
subcellular
local
antivir
activ
perform
imag
studi
cell
enabl
us
monitor
compart
avoid
potenti
heterotyp
interact
endogen
ifitm
live
imag
cell
reveal
rel
littl
coloc
steadyst
mander
correl
coeffici
mcc
supplementari
result
supplementari
fig
instead
significantli
greater
overlap
mcc
mcc
observ
supplementari
result
supplementari
fig
show
larg
resid
late
endocyt
vesicl
consist
previou
live
cell
imag
studi
wt
hela
use
didlabel
iav
epifluoresc
imag
observ
coloc
major
intern
viru
particl
prior
lipid
mix
fig
b
supplementari
result
supplementari
movi
anoth
percent
diddequench
event
occur
compart
without
detect
fig
latter
event
vesicl
observ
coloc
diddequench
puncta
later
time
secondari
dequench
event
could
occasion
observ
fig
supplementari
result
supplementari
movi
secondari
diddequench
like
repres
dye
diffus
due
endosom
fusion
vesicl
expans
limit
membran
reintroduct
hela
cell
significantli
alter
total
percentag
iav
particl
undergo
lipid
mix
h
postinfect
supplementari
result
supplementari
fig
consist
previou
experi
fig
result
show
viru
particl
may
fuse
vesicl
significantli
inhibit
iav
lipid
mix
hemifus
endocyt
membran
importantli
coloc
nearli
percent
didiav
particl
time
lipid
mix
fig
markedli
decreas
vsv
particl
pseudotyp
glycoprotein
complex
gpc
lassa
viru
lasv
latepenetr
arenaviru
restrict
fig
supplementari
result
supplementari
movi
experi
iav
lasv
gpcpseudotyp
vsv
still
traffick
late
endocyt
compart
indic
coloc
fig
extent
coloc
virus
hour
postinfect
similar
supplementari
result
supplementari
fig
howev
lasv
gpcbear
particl
dequench
endosom
acquir
fig
iav
dequench
gener
occur
shortli
coloc
fig
investig
specif
traffick
toward
restrict
virus
analyz
vsv
particl
pseudotyp
glycoprotein
ebola
viru
ebov
late
endosomelysosom
enter
viru
restrict
like
iav
major
didebov
particl
coloc
prior
lipid
mix
fig
f
result
demonstr
first
time
incom
viru
particl
interact
vesicl
prior
fusion
phenomenon
specif
restrict
virus
iav
ebov
evalu
featur
requir
traffick
incom
iav
particl
analyz
lossoffunct
key
posttransl
modif
mutant
particular
evalu
allel
yield
truncat
mutant
suggest
affect
host
cell
suscept
iav
stabl
express
cell
reveal
peripher
plasma
membran
distribut
supplementari
result
supplementari
fig
lower
protein
level
reduc
antivir
activ
iav
compar
wt
supplementari
result
supplementari
fig
c
consist
previou
moreov
also
exhibit
decreas
antivir
activ
toward
iav
zikv
compar
similar
level
full
length
hela
cell
fig
analyz
traffick
iav
infect
gener
construct
sitespecif
fluorophor
label
bodipytz
widefield
epifluoresc
microscopi
show
bodipylabel
construct
primarili
intracellular
vesicl
supplementari
result
supplementari
fig
confoc
fluoresc
microscopi
show
exhibit
slightli
costain
plasma
membran
marker
compar
construct
supplementari
result
supplementari
fig
b
didiav
imag
studi
observ
percent
reduct
number
iav
particl
coloc
time
lipid
mix
versu
wt
fig
indic
truncat
protein
less
like
incorpor
complet
absent
endosom
compart
support
viral
fusion
fig
reintroduct
wt
hela
cell
also
significantli
alter
total
percentag
iav
particl
undergo
lipid
mix
h
postinfect
supplementari
result
supplementari
fig
result
demonstr
quantit
differ
traffick
incom
viru
particl
correl
alter
steadyst
local
antivir
activ
suggest
direct
engag
fusion
vesicl
pathogen
import
cellular
mechan
action
investig
mechan
control
traffick
viru
particl
analyz
sitespecif
mutant
previou
studi
group
demonstr
human
promin
site
crucial
antivir
activ
toward
well
howev
mechan
sitespecif
spalmitoyl
regul
antivir
activ
unclear
sinc
similar
level
steadyst
protein
express
cellular
local
pattern
observ
wt
individu
ala
mutant
therefor
gener
construct
cystoala
mutant
analyz
traffick
properti
iav
entri
cystoala
mutant
express
similar
level
wt
show
decreas
level
sfattyacyl
hela
cell
particularli
mutant
supplementari
result
supplementari
fig
b
although
rel
level
sitespecif
sfattyacyl
tagmodifi
construct
human
less
dramat
previou
studi
murin
still
promin
site
importantli
mutat
ala
significantli
decreas
antivir
activ
toward
iav
wherea
ala
mutant
retain
activ
supplementari
result
supplementari
fig
consist
previou
studi
steadyst
local
bodipylabel
construct
similar
wt
supplementari
result
supplementari
fig
howev
traffick
coloc
mutant
dequench
didiav
particl
significantli
decreas
percent
compar
wt
ala
mutant
fig
supplementari
result
supplementari
fig
comparison
wt
mutant
traffick
didiav
particl
also
delay
supplementari
result
supplementari
fig
result
show
sfattyacyl
significantli
affect
steadyst
cellular
distribut
sitespecif
spalmitoyl
import
rate
traffick
iav
particl
infect
reveal
sitespecif
fluorophor
label
live
cell
imag
import
ifnstimul
effector
prevent
divers
viru
infect
varieti
vertebr
anim
emerg
key
viru
suscept
factor
human
nonetheless
precis
cellular
biochem
mechan
action
small
membran
protein
challeng
elucid
gener
singl
multipl
ifitmdefici
mammalian
cell
line
demonstr
may
redund
act
synergist
toward
differ
restrict
virus
stimul
cell
furthermor
demonstr
ifitm
function
dosedepend
fashion
affect
earli
stage
exogen
cargo
pathogen
uptak
rather
enhanc
traffick
turnov
late
endocyt
cargo
lysosom
absenc
infect
cell
stimul
show
slower
rate
egfr
turnov
iav
infect
observ
fluorescentlylabel
iav
particl
enter
host
cell
undergo
hemifus
similar
rate
wt
cell
consist
previou
sirna
knockdown
studi
howev
cell
observ
fluorescentlylabel
iav
particl
traffic
approxim
minut
slowli
averag
lysosom
find
suggest
beyond
potenti
inhibit
viru
pore
may
prevent
viru
entri
alter
rate
virusendosom
fusion
andor
acceler
traffick
endosom
cargo
lysosom
destruct
previou
studi
correl
cellular
distribut
antivir
activ
traffick
interact
virus
infect
unknown
use
sitespecif
fluorophor
label
mammalian
cell
abl
directli
visual
traffick
fluorescentlylabel
viru
particl
observ
first
time
vesicl
fuse
incom
virusbear
vesicl
prior
hemifus
importantli
vesicl
fusion
coloc
prior
hemifus
specif
restrict
virus
iav
pseudotyp
ebov
lasvpseudotyp
viru
particl
coloc
significantli
reduc
lossoffunct
mutant
abil
ifitm
engag
endosom
bear
incom
viru
particl
enhanc
traffick
late
endocyt
compart
provid
import
mechan
explain
specif
ifitm
differ
virus
potenti
predict
point
viral
entri
host
cell
differ
virus
may
therefor
initi
fusion
differ
subset
late
endolysosom
compart
exhibit
differenti
sensit
ifn
effector
express
level
traffick
properti
interact
readili
appar
bulk
viral
entri
studi
highlight
util
sitespecif
protein
label
live
singleparticl
imag
approach
facilit
futur
studi
virushost
factor
dynam
abil
imag
traffick
live
cell
reveal
interact
pathogen
infect
also
uncov
posttransl
modif
regul
function
small
membran
protein
initi
discov
determin
endogen
specif
site
well
confirm
modif
palmit
result
also
confirm
also
shown
spalmitoyl
regul
antivir
activ
unclear
steadyst
local
studi
use
sitespecif
fluorophor
label
live
cell
imag
infect
observ
inhibit
spalmitoyl
sitedirect
mutagenesi
impair
traffick
incom
iav
particl
thu
reveal
sitespecif
spalmitoyl
regul
antivir
activ
chemic
imag
approach
describ
uncov
import
aspect
ifitm
engag
pathogen
infect
well
key
regulatori
mechan
facilit
analysi
host
factor
involv
pathogen
restrict
nonetheless
key
question
still
remain
regard
cellular
pathway
biochem
mechan
ifneffector
prevent
pathogen
entri
acceler
traffick
incom
viral
particl
lysosom
destruct
abil
conduct
sitespecif
label
uniqu
chemic
reactiv
enabl
addit
imag
studi
discoveri
specif
proteinprotein
interact
partner
reconstitut
lipid
isoform
biochem
structur
studi
futur
hela
order
atcc
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
contain
fetal
bovin
serum
fb
hyclon
antibodi
order
cell
signal
technolog
proteintech
group
abgent
polyclon
vwr
intern
egfr
antibodi
abcam
tfr
antibodi
r
system
alexafluor
santa
cruz
biotechnolog
influenza
viru
nucleoprotein
antibodi
abcam
alexafluor
antibodi
label
kit
order
life
technolog
secondari
antibodi
hrpconjug
goat
antimous
igg
hcl
hrpconjug
goat
antirabbit
igg
hcl
purchas
jackson
immunoresearch
sheep
igg
horseradish
peroxidaseconjug
antibodi
order
fisher
scientif
antiha
antibodi
conjug
purchas
life
technolog
antiha
hrpconjug
antibodi
order
roch
anticalnexin
abcam
dextranalexafluor
dextranphrodor
transferrinalexafluor
recombin
human
egf
life
technolog
human
holotransferrin
sigma
aldrich
human
cell
signal
technolog
influenza
charl
river
laboratori
magic
red
cathepsin
b
assay
kit
immunochemistri
technolog
bafilomycin
abcam
tamra
special
formul
anaspec
quikchang
ii
sitedirect
mutagenesi
kit
agil
technolog
endonucleas
new
england
biolab
clone
pcr
amplif
insert
vector
mutant
gener
use
quikchang
multi
sitedirect
mutagenesi
kit
stratagen
plasmid
grna
basic
vector
gift
dr
wensheng
wei
peke
univers
cell
lyse
genom
extract
transfect
grna
plamsid
h
grna
target
site
amplifi
use
genom
pcr
primer
aggaaact
gttgagaaaccgaa
gctagtggatagccggggac
pcr
product
gel
purifi
follow
denatur
anneal
anneal
mixtur
treat
endonucleas
min
cleavag
effici
monitor
gel
electrophoresi
grna
plasmid
construct
insert
grna
oligo
vector
golden
gate
ligat
cell
transfect
grna
ratio
ug
h
cell
detach
split
two
part
one
part
lyse
assay
check
cleavag
effici
specif
grna
anoth
part
reseed
sixwel
plate
differ
dilut
puromycin
ad
select
posit
clone
select
one
week
separ
cell
coloni
pick
new
plate
new
cell
coloni
expand
analyz
western
blot
genom
sequenc
evalu
knockout
effici
western
blot
analysi
cell
lyse
sodium
dodecyl
sulfat
sd
lysi
buffer
sd
mm
tri
mm
edta
boil
min
immunoprecipit
cell
lyse
brij
buffer
mm
triethanolamin
tea
mm
nacl
contain
edtafre
proteas
inhibitor
mixtur
incub
antiha
affin
bead
sigma
primari
antibodi
use
dilut
secondari
antibodi
use
genom
sequenc
ifitm
clone
total
genom
extract
genom
extract
kit
qiagen
target
genom
site
amplifi
genespecif
primer
amplifi
fragment
ad
datp
end
taq
polymeras
ligat
vector
transform
ten
bacteria
coloni
pick
randomli
sent
sequenc
hela
vero
cell
maintain
dmem
supplement
fb
hela
cell
use
function
studi
viral
replic
assay
wherea
vero
cell
use
viru
product
viru
titrat
cell
line
test
neg
contamin
mycoplasma
obtain
atcc
except
hela
cell
infect
influenza
viru
moi
h
infect
cell
wash
pb
harvest
use
trypsinedta
cell
fix
paraformaldehyd
pfa
min
permeat
triton
min
cell
stain
antiinfluenza
nucleoprotein
np
antibodi
directli
conjug
alexafluor
use
antibodi
label
kit
invitrogen
antibodi
dilut
triton
pb
cell
stain
min
cell
wash
twice
triton
pb
antibodi
treatment
pb
use
final
resuspens
cell
cytometr
analysi
use
fac
canto
ii
flow
cytomet
bd
bioscienc
hela
cell
seed
plate
cellswel
incub
overnight
h
presenc
absenc
concentr
next
cell
wash
optimem
gibco
prior
infect
virus
dilut
optimem
indic
moi
cell
inocul
h
follow
incub
viral
inoculum
remov
cultur
wash
three
time
optimem
dmem
read
treatment
continu
throughout
experi
cell
infect
gfptag
virus
harvest
indic
time
point
measur
infect
flow
cytometri
gener
viral
stock
follow
virus
previous
describ
deriv
deriv
pbelownvgfprz
ic
deriv
fulllength
infecti
clone
strain
deriv
infecti
clone
deriv
infecti
clone
ponnvgfp
vsvgfp
gener
provid
john
rose
yale
zikv
obtain
cdc
ft
collin
amplifi
cell
titer
plaqu
assay
cell
experi
wnv
carri
biosafeti
level
contain
complianc
institut
feder
guidelin
infect
cell
harvest
accumax
cell
dissoci
medium
ebiosci
transfer
block
contain
pfa
cell
pellet
rcf
min
resuspend
cold
pb
contain
fb
store
fac
analysi
cell
infect
zikv
harvest
describ
subsequ
stain
use
monoclon
antibodi
flaviviru
group
antigen
millipor
primari
antibodi
antirabbit
secondari
antibodi
addit
cell
supernat
zikv
infect
harvest
determin
viral
titer
standard
plaqu
assay
perform
cell
sampl
analyz
use
lsrii
flow
cytomet
bd
bioscienc
equip
nm
nm
laser
detect
gfp
yfp
venu
rfp
data
analyz
use
flowjo
softwar
treestar
compens
matrix
cell
grown
glass
coverslip
sixwel
plate
treatment
cell
wash
pb
twice
fix
pfa
min
permeabil
triton
min
block
bovin
serum
albumin
bsa
roch
h
incub
primari
antibodi
dilut
bsa
h
follow
secondari
antibodi
h
room
temperatur
final
coverslip
mount
onto
slide
use
mount
medium
contain
dapi
cell
examin
invert
lsm
laser
scan
confoc
microscop
zeiss
cell
serumstarv
min
dmem
cell
incub
ice
min
follow
addit
transferrin
invitrogen
dmem
min
ice
cell
transfer
min
min
pellet
wash
icecold
pb
acidwash
glycin
mm
nacl
ph
twice
wash
pb
fix
wtvol
pfa
sucros
pb
flow
cytometr
analysi
describ
synthesi
dftat
yenchih
wang
previous
pretreat
without
ugml
h
cell
incub
um
dftat
dmem
indic
time
place
ice
wash
icecold
pb
three
time
fix
wtvol
pfa
sucros
pb
flow
cytometr
analysi
fluoresc
microscopi
cell
cultur
confluenc
wash
twice
pb
starv
serumfre
dmem
h
maxim
surfac
epiderm
growth
factor
receptor
egfr
pretreat
cycloheximid
h
serumfre
dmem
prevent
synthesi
new
egfr
stimul
egf
immedi
cell
continu
stimul
ngml
egf
min
presenc
cycloheximid
level
egfr
tubulin
determin
western
blot
cell
surfac
stain
experi
cell
incub
primari
antiegfr
antibodi
ice
min
wash
three
time
pb
alexafluor
secondari
antibodi
incub
cell
min
ice
wash
three
time
pb
cell
suspend
fb
pb
immedi
analyz
via
flow
cytometri
tfr
turnov
experi
cell
cultur
confluenc
wash
twice
pb
starv
serumfre
dmem
h
pretreat
cycloheximid
h
serumfre
dmem
prevent
synthesi
new
transferrin
receptor
tfr
immedi
cell
continu
stimul
tf
min
presenc
cycloheximid
level
tfr
tubulin
determin
western
blot
cell
incub
h
cultur
medium
contain
ugml
phrodor
dextran
follow
h
chase
fluorophorefre
medium
promot
lysosom
accumul
dextran
cell
incub
medium
contain
ugml
dextranalexafluor
min
replac
fluorophorefre
medium
time
point
note
cell
fix
icecold
pfa
immunofluoresc
stain
cathepsin
b
activ
assay
use
cathepsin
b
activ
kit
follow
protocol
provid
manufactur
treatment
h
without
bafilomycin
cell
incub
magic
red
min
wash
twice
pb
cell
fix
use
pfa
analyz
flow
cytometri
activitybas
label
cathepsin
vergent
bioscienc
pan
cathepsin
probe
perform
previous
report
minor
modif
briefli
cell
seed
h
prior
label
cell
activ
h
prior
label
media
replac
cell
treat
pan
cathepsin
probe
h
cell
wash
pb
lyse
ice
hypoton
lysi
buffer
mm
pipe
ph
mm
kcl
mm
mm
edta
mm
dtt
cell
debri
remov
spin
lysat
g
min
supernat
mix
sampl
load
buffer
total
protein
analyz
sdspage
gel
wash
twice
deioniz
water
ingel
fluoresc
analysi
biorad
chemidoc
mp
imag
system
coomassi
stain
transfer
western
blot
analysi
purifi
influenza
viru
recombin
vsv
express
lasv
gpc
gener
previous
describ
label
selfquench
concentr
lipophil
dye
tetramethylindodicarbocyanin
life
technolog
purifi
viru
mgml
pb
incub
agit
h
viru
separ
excess
dye
ultracentrifug
sucros
cushion
h
g
use
rotor
beckman
coulter
label
viru
pellet
resuspend
pb
viral
protein
concentr
mgml
aliquot
store
use
live
cell
imag
studi
hela
cell
seed
onto
mm
glass
bottom
dish
approxim
confluenc
imag
next
day
follow
adher
cell
transfect
plasmid
interest
contain
variant
per
dish
mmpylrsafpyltrnacua
plasmid
per
dish
use
viafect
promega
complet
cell
growth
media
contain
unnatur
amino
acid
tcok
overnight
incub
cell
media
chang
fresh
cell
growth
media
without
tcok
anoth
h
cultur
cell
label
tetrazinefluorophor
nm
fluorobrit
dmem
life
technolog
min
wash
complet
cell
growth
media
time
h
widefield
epifluoresc
microscopi
cell
transduc
celllight
vector
life
technolog
earli
endosom
late
endosom
lysosom
approxim
h
prior
imag
accord
manufactur
instruct
livecel
microscopi
perform
previous
describ
widefield
epifluoresc
microscop
zeiss
equip
object
dapigfptexa
filter
set
heat
environment
enclosur
maintain
hela
cell
monolay
seed
onto
fibronectinco
mm
glass
coverslip
dish
mattek
h
prior
experi
cell
chill
ice
sever
minut
spinocul
didlabel
viru
onto
monolay
g
min
unbound
particl
remov
five
wash
cold
pb
cold
imag
buffer
mm
nacl
mm
kcl
mm
mm
hepe
mm
sucros
hoechst
fb
ad
cover
cell
dish
immedi
mount
microscop
object
focus
coverslip
dish
flood
ml
warm
imag
buffer
mark
start
experi
imag
acquir
everi
durat
experi
use
singl
zsection
encompass
nearli
cellassoci
particl
confoc
microscopi
hela
cell
seed
mm
glass
bottom
dish
ibidi
cultur
overnight
next
day
cell
transfect
plasmid
interest
contain
tag
codon
per
dish
pylrspyltrna
plasmid
per
dish
use
lipofectamin
complet
cell
growth
media
contain
atcok
h
incub
cell
media
chang
fresh
cell
growth
media
without
uaa
anoth
h
cultur
cell
label
tetrazinebodipi
nm
fluorobrit
dmem
life
technolog
fb
h
wash
fluorobrit
dmem
life
technolog
fb
time
h
final
cell
stain
nucblu
live
cell
stain
life
technolog
min
imag
fluorobrit
fb
confoc
microscopi
plasma
membran
stain
cell
stain
cellmask
red
life
technolog
live
cell
imag
solut
lci
min
wash
lci
three
time
stain
nucblu
live
cell
stain
cell
imag
invert
lsm
laser
scan
confoc
microscop
zeiss
zeiss
planapochromat
oil
immers
object
microscop
equip
stagetop
incub
set
live
cell
imag
hoescht
excit
nm
laser
emiss
spectra
collect
nm
nm
tzbodipi
excit
nm
laser
emiss
spectra
collect
nm
nm
cellmask
red
excit
nm
laser
emiss
spectra
collect
nm
nm
imag
acquir
zen
blue
softwar
zeiss
analyz
imagej
nih
pearson
correl
coeffici
calcul
imagej
use
coloc
plugin
imag
analysi
singleparticl
track
perform
use
voloc
softwar
perkinelm
previous
describ
imag
file
manipul
apart
minor
adjust
bright
contrast
viral
puncta
threshold
initi
intens
size
puncta
fall
outsid
rang
expect
individu
didlabel
virion
exclud
singleparticl
analysi
virion
consid
coloc
cellular
marker
punctum
exceed
background
signal
gfp
bodipi
puncta
cotraffick
greater
overlap
signal
mean
measur
standard
deviat
deriv
three
separ
experi
unless
otherwis
indic
western
blot
analysi
hela
cell
seed
well
plate
cultur
overnight
ko
cell
transfect
mutant
presenc
atcok
h
hela
wt
cell
treat
without
ngml
h
level
determin
western
blot
immunofluoresc
analysi
ko
cell
transfect
mutant
presenc
atcok
h
hela
wt
cell
treat
without
ngml
h
cell
fix
formaldehyd
permeabil
saponin
immunostain
rabbit
antirabbitalexa
fluor
conjug
confoc
fluoresc
imag
hoescht
blue
use
stain
nuclei
cell
imag
invert
lsm
laser
scan
confoc
microscop
zeiss
zeiss
planapochromat
oil
immers
object
imag
taken
ident
confoc
microscop
set
flow
cytometri
analysi
ko
cell
transfect
mutant
presenc
atcok
h
hela
wt
cell
treat
without
ngml
h
cell
wash
twice
pb
fix
ul
pb
pfa
min
fix
cell
permeabil
ul
saponin
pb
min
block
ul
bsa
saponin
pb
min
cell
treat
rabbit
antirabbitalexa
fluor
pb
saponin
three
wash
pb
cell
resuspend
ul
pb
bsa
saponin
sampl
analyz
flow
cytometri
bd
lsrii
data
analysi
perform
use
flowjo
softwar
ko
hela
cell
seed
well
plate
corn
cultur
overnight
cell
cotransfect
construct
mmpylrsafpyltrna
plasmid
use
lipofectamin
ml
complet
cell
growth
media
contain
ul
mm
bock
final
concentr
mm
h
cell
infect
influenza
viru
viru
moi
h
infect
cell
trypsin
collect
cluster
tube
corn
cell
wash
twice
pb
fix
ul
pb
pfa
min
fix
cell
permeabil
ul
saponin
pb
min
block
ul
bsa
saponin
pb
min
cell
treat
antiinfluenza
np
antibodi
conjug
antiha
antibodi
conjug
pb
saponin
three
wash
pb
cell
resuspend
ul
pb
bsa
saponin
sampl
analyz
flow
cytometri
bd
lsrii
sampl
first
gate
haposit
stain
indic
success
transfect
npposit
percentag
npposit
stain
indic
success
infect
hatag
epitop
deriv
influenza
viru
strain
present
strain
influenza
viru
data
analysi
perform
use
flowjo
softwar
metabol
label
cell
alkynepalmit
acid
report
perform
previous
modif
azrho
synthes
previous
ko
hela
cell
transfect
construct
describ
h
cell
incub
dmem
contain
fb
h
cell
harvest
wash
pb
lyse
brij
sigma
mm
tea
mm
nacl
ph
roch
proteas
inhibitor
unitsml
benzonas
emd
protein
concentr
determin
bca
assay
immunoprecipit
total
protein
ad
antiha
antibodyconjug
agaros
sigma
total
volum
rock
h
agaros
bead
wash
resuspens
mm
hepe
buffer
contain
mm
nacl
ph
centrifug
g
bead
resuspend
buffer
cuaac
reactant
solut
mm
azidorhodamin
final
concentr
mm
freshli
prepar
final
concentr
mm
sigma
mm
freshli
prepar
tcep
final
concentr
mm
mm
tri
methyl
amin
tbta
final
concentr
ad
sampl
rock
room
temperatur
h
wash
twice
ripa
buffer
laemmli
sampl
buffer
ad
sampl
ratio
buffer
sampl
heat
min
separ
gel
electrophoresi
ingel
fluoresc
scan
perform
use
biorad
chemidoc
mp
imag
system
western
blot
hatag
protein
perform
use
antiha
hrp
conjug
antibodi
roch
quantif
band
intens
fluoresc
gel
western
blot
perform
imag
lab
biorad
data
three
biolog
replic
quantifi
averag
plot
